Quantcast
Channel: BioTuesdays » myo-inositol levels
Browsing latest articles
Browse All 2 View Live

Image may be NSFW.
Clik here to view.

Transition partner enrols first patient in AD study

Transition Therapeutics’ (TSX:TTH; NASDAQ:TTHI) licensing partner, Elan Corp., has enrolled the first patient in a Phase 2 study of ELND005 for the treatment of agitation/aggression in patients with...

View Article



Image may be NSFW.
Clik here to view.

Transition, Perrigo amend ELND005 program

Transition Therapeutics (NASDAQ:TTHI; TSX:TTH) and Perrigo plc (NYSE,TASE:PRGO) have amended the development and commercialization program for their ELND005 drug candidate, which is being investigated...

View Article
Browsing latest articles
Browse All 2 View Live




Latest Images